Compare Workday Inc (WDAY) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Workday Inc vs Zimmer Biomet Holdings Inc — how do they compare? Workday Inc trades at $186.59 (market cap $45.26B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Workday Inc is far larger — about 2.7× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Workday Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Workday Inc for 38 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WDAY | ZBH | |
|---|---|---|
Market Cap | $45.26B | $16.95B |
Volume | 2,342,190 | 2,505,240 |
Sector | Technology | Health |
52-Week High | $245.67 | $103.98 |
52-Week Low | $112.55 | $79.58 |
Typical Hold Time | 38 Days | 89 Days |
Enterprise Value | $45.63B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Workday (WDAY) trades at $187.81, up 1.93% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $8.45B in 2025, and net income margin improved to 12.32%. Recent news highlights AI product launches and strategic partnerships, alongside a 2.5% headcount reduction aimed at realigning for growth.
WDAY presents a growth opportunity driven by AI integration and expanding market presence, but faces risks from competitive pressures and execution challenges. Analyst consensus is bullish with a $202.92 price target, though valuation multiples remain elevated. Investors should weigh strong fundamentals against potential volatility from market sentiment and operational adjustments.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
